EichorEICHOR
Location: Sydney Synced from ClinicalTrials.gov · August 07, 2026

Clinical studies recruiting near Sydney

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

The Efemoral Vascular Scaffold System (EVSS) for the Treatment of Patients With Symptomatic Peripheral Vascular Disease
NA · Northern Health · Efemoral Medical, Inc. · NCT04584632Precision Medicine for Every Child With Cancer
Phase N/A · Sydney Children's Hospital, Randwick · Australian & New Zealand Children's Haematology/Oncology Gro · NCT05504772Single-dose Preoperative Partial Breast Irradiation in Low-risk Breast Cancer Patients
NA · GenesisCare · Amsterdam UMC, location VUmc · NCT05350722This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide W
Phase 3 · Pfizer · NCT07028853Red Blood Cell Transfusion in ECMO - A Feasibility Trial
NA · St Vincent's Health Sydney · Australian and New Zealand Intensive Care Research Centre · NCT05814094AusCADASIL: An Australian Cohort of CADASIL
Phase N/A · Prince of Wales Hospital · Perminder Sachdev · NCT06148051Novel Treatment Delivery of ECAP-controlled Closed-loop SCS for Chronic Pain
NA · Women's Health & Research Institute of Australia · Saluda Medical Pty Ltd · NCT04662905A Global Study of Novel Agents in Paediatric and Adolescent Relapsed and Refractory B-cell Non-Hodgkin Lymphoma
Phase 2/Phase 3 · The Children's Hospital at Westmead · University of Birmingham · NCT05991388Interfant-21 Treatment Protocol for Infants Under 1 Year With KMT2A-rearranged ALL or Mixed Phenotype Acute Leukemia
Phase 3 · Sydney Childrens Hospital · Princess Maxima Center for Pediatric Oncology · NCT05327894A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) G
Phase 1/Phase 2 · National Cancer Institute (NCI) · NCT05099003This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in
Phase 3 · Campbelltown Hospital · Pfizer · NCT06758401Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed
Phase 3 · National Cancer Institute (NCI) · NCT06172296Tissue Repair Gel in Venous Leg Ulcers in AU/US
Phase 3 · Clincial Research Site 85 · TR Therapeutics · NCT06707103An Extension Study to Assess Safety and Efficacy of Remibrutinib in Participants With Moderate to Severe HS
Phase 3 · Novartis Investigative Site · Novartis Pharmaceuticals · NCT07665437A Study to Assess Safety, Tolerability and Imaging Characteristics of [68Ga]Ga-DPI-4452 and to Assess Safety, Tolerabili
Phase 1/Phase 2 · UNSW Sydney, St Vincent's Hospital Sydney · Lumara Bio Oncologics GmbH · NCT05706129Phase 2 Study of ADX-038 in Complement-Mediated Kidney Disease
Phase 2 · ADARx Clinical Site · ADARx Pharmaceuticals, Inc. · NCT06989359A Phase 2 Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, in Adults and Children With PIK3CA Related Overgrowth Spe
Phase 2 · Relay Therapeutics, Inc. · NCT06789913Phase 1a/1b Study of TRB-061 in Healthy Participants & Patients With Atopic Dermatitis
Phase 1 · TRex Bio, Inc. · NCT06934252PSMA PET Combined With MRI for the Detection of PCa
Phase 3 · St Vincent's Hospital Sydney · Telix Pharmaceuticals (Innovations) Pty Limited · NCT07052214A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma
Phase 2 · Children's Oncology Group · NCT06368817The Oxford Risk Factors And Non-Invasive Imaging Study
Phase N/A · The University of Sydney · University of Oxford · NCT05169333A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma
Phase 2/Phase 3 · National Cancer Institute (NCI) · NCT05691478Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiov
Phase 3 · Momentum Clinical Research - Darlinghurst · Amgen · NCT07037433A Study of MT-303 in Adults With Advanced or Metastatic GPC3-Expressing Cancers, Including HCC
Phase 1 · St Vincent's Hospital · Myeloid Therapeutics · NCT06478693A Study Assessing HMB-002 in Participants With Von Willebrand Disease
Phase 1/Phase 2 · Hemab ApS · NCT06754852Ultra-Early, Minimally inVAsive intraCerebral Haemorrhage evacUATion Versus Standard trEatment
NA · Prince of Wales Hospital · University of Melbourne · NCT04434807A Study of GS-3242 in Combination With Lenacapavir Versus Biktarvy in Virologically Suppressed People With HIV-1
Phase 2 · Momentum Clinical Research Darlinghurst · Gilead Sciences · NCT07645287Combination Therapy for the Treatment of Diffuse Midline Gliomas
Phase 2 · Sydney Children's Hospital · University of California, San Francisco · NCT05009992A Study of Baricitinib (LY3009104) to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Dia
Phase 3 · Eli Lilly and Company · NCT07222332A Clinical Study of MK-4716 in People With Certain Solid Tumors (MK-4716-001)
Phase 1 · Blacktown Hospital ( Site 0455) · Merck Sharp & Dohme LLC · NCT07247110
Look up another city
Look up another condition
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.